NY-ESO-1 (53-62) is an immunogenic peptide epitope derived from the cancer-testis antigen NY-ESO-1. Its sequence supports MHC-binding and epitope-structure studies. Researchers employ it to investigate T-cell receptor engagement. The peptide aids mapping of antigenic determinants within germline-restricted proteins.
CAT No: C08179
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.